Mulmit

ENDRA Life Sciences Inc.ENDRA Life Sciences Inc.

NDRA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2020-12-310-11,501,917-11,725,501
2019-12-310-10,843,592-13,305,964
2018-12-316,174-9,019,008-9,796,261
2017-12-31351,622-4,626,058-5,376,962

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-03-02Tokman Alexander YChief Executive Officer26,921
2026-03-02Jacroux RichardChief Financial Officer13,461
2026-01-21DIGIANDOMENICO ANTHONY60,324
2026-01-21Harsh Michael60,324
2026-01-21Jacroux RichardChief Financial Officer20,000
2026-01-21Basenese Lou60,324
2026-01-21Tokman Alexander YChief Executive Officer75,000
2025-10-10DIGIANDOMENICO ANTHONY70,822
2025-10-10DIGIANDOMENICO ANTHONY141,644
2025-06-11Basenese Lou5,384
2025-06-11Harsh Michael5,384
2025-06-11DIGIANDOMENICO ANTHONY5,384

8-K events

FiledItems
2026-08-17Results of operations · Financial statements and exhibits
2026-07-09Other events
2026-06-26Entry into a material agreement · Change in control · Regulation FD disclosure · Other events · Financial statements and exhibits
2026-06-25Regulation FD disclosure · Financial statements and exhibits
2026-05-28Entry into a material agreement · Unregistered sales of equity securities · Other events · Financial statements and exhibits
2026-04-21Delisting or listing-standard notice
2026-03-31Results of operations · Financial statements and exhibits
2026-03-25Costs associated with exit or disposal activities · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…